Cynical Science and Stem Cells

So powerful has the language of science become that it has in effect been hijacked by those who seek to discredit or even derail it. Two cases in point: Creationists are repackaging their message as the pseudo-science of "intelligent design theory." And pro-life groups are misusing real science, remarkable advances with adult stem cells, to argue that there is no need for embryonic stem cell research--research that carries with it virtually limitless potential for the alleviation of human suffer

Written byArlene Judith Klotzko
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

The real scientists seem to be losing the argument. The National Institutes of Health canceled the first meeting of the committee set up to review applications seeking federal funds for human embryonic stem cell research. For some time, there have been ominous signs. Shortly after taking office, President George W. Bush asked Tommy Thompson, his Secretary of Health and Human Services, to review the legal basis for the NIH stem cell guidelines. (See "On the Brink") With this latest development, the future of stem cell research--and with it the prospect of finding treatments for hitherto intractable chronic disease and disability--is clearly at grave risk.

Embryonic stem cells have the potential to develop into all basic tissue types--but not into a human being. They could provide a virtually limitless source of tissue for transplantation. Adult stem cells are more problematic. While their destinies are not as limited as we had once ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies